Compare REI & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REI | RPID |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.3M | 204.3M |
| IPO Year | 2013 | 2021 |
| Metric | REI | RPID |
|---|---|---|
| Price | $1.33 | $2.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 5.4M | 223.6K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $307,178,072.00 | $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | $10.17 | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $0.72 | $2.01 |
| 52 Week High | $1.65 | $4.94 |
| Indicator | REI | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 38.81 |
| Support Level | $1.22 | $2.01 |
| Resistance Level | $1.64 | $2.43 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 12.16 | 48.12 |
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.